Novel avermectins are produced from known microorganisms
US5070015A · kind A · utility
5Cited by
5References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1990 |
| Grant date | Dec 3, 1991 |
| Priority date | — |
| Expiry date | Oct 15, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/897
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Incubation of 13-deoxy ivermectin aglycone with a species of B. subtilis and of S. griseus results in the production of 13-.beta. ivermectin monoglucopyranoside as the major product and of 5-.beta. ivermectin monoglucopyranoside as the minor product.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.